TD Asset Management’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.98M | Sell |
286,264
-9,590
| -3% | -$301K | 0.01% | 660 |
|
|
2025
Q1 | $8.78M | Sell |
295,854
-21,622
| -7% | -$642K | 0.01% | 667 |
|
|
2024
Q4 | $9.37M | Buy |
317,476
+4,524
| +1% | +$133K | 0.01% | 662 |
|
|
2024
Q3 | $9.83M | Buy |
312,952
+48,056
| +18% | +$1.51M | 0.01% | 647 |
|
|
2024
Q2 | $8.98M | Buy |
264,896
+49,882
| +23% | +$1.69M | 0.01% | 638 |
|
|
2024
Q1 | $14M | Sell |
215,014
-131,916
| -38% | -$8.57M | 0.01% | 564 |
|
|
2023
Q4 | $23.7M | Buy |
346,930
+45,010
| +15% | +$3.08M | 0.02% | 434 |
|
|
2023
Q3 | $15.7M | Buy |
301,920
+158,086
| +110% | +$8.2M | 0.02% | 488 |
|
|
2023
Q2 | $8.62M | Buy |
143,834
+47,581
| +49% | +$2.85M | 0.01% | 632 |
|
|
2023
Q1 | $4.76M | Buy |
96,253
+3,347
| +4% | +$165K | 0.01% | 762 |
|
|
2022
Q4 | $5.3M | Buy |
92,906
+12,500
| +16% | +$713K | 0.01% | 738 |
|
|
2022
Q3 | $3.69M | Buy |
80,406
+52,900
| +192% | +$2.43M | ﹤0.01% | 825 |
|
|
2022
Q2 | $1.03M | Hold |
27,506
| – | – | ﹤0.01% | 1179 |
|
|
2022
Q1 | $822K | Hold |
27,506
| – | – | ﹤0.01% | 1265 |
|
|
2021
Q4 | $942K | Hold |
27,506
| – | – | ﹤0.01% | 1290 |
|
|
2021
Q3 | $1.02M | Hold |
27,506
| – | – | ﹤0.01% | 1246 |
|
|
2021
Q2 | $900K | Hold |
27,506
| – | – | ﹤0.01% | 1284 |
|
|
2021
Q1 | $1.17M | Buy |
+27,506
| New | +$1.17M | ﹤0.01% | 1238 |
|